Top Biotechnology & Medical Research stocks in North America

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name	Market Cap	Price to Earnings TTM	Dividend Yield % TTM
BPMCBlueprint Medicines	$8.37bn	n/a	n/a
CERECerevel Therapeutics Holdings	$8.19bn	n/a	n/a
IBRXImmunitybio	$8.11bn	n/a	n/a
NUVLNuvalent,	$8.00bn	n/a	n/a
TEMTempus AI	$7.89bn	n/a	n/a
CRLCharles River Laboratories International	$7.65bn	58.95	n/a
PCVXVaxcyte	$7.56bn	n/a	n/a
TECHBIO-TECHNE	$7.42bn	38.64	0.68%
MRUSMerus NV	$7.35bn	n/a	n/a
QGENQiagen NV	$7.20bn	15.51	0.72%
IMVTImmunovant	$7.01bn	n/a	n/a
CELCCelcuity	$6.95bn	n/a	n/a
CDTXCidara Therapeutics	$6.95bn	n/a	n/a
ACLXArcellx	$6.73bn	n/a	n/a
KYMRKymera Therapeutics	$6.63bn	n/a	n/a
PTGXProtagonist Therapeutics	$6.56bn	n/a	n/a
RETAReata Pharmaceuticals	$6.52bn	n/a	n/a
SYRESpyre Therapeutics	$6.45bn	n/a	n/a
CNTACentessa Pharmaceuticals	$6.16bn	n/a	n/a
ALKSAlkermes	$6.16bn	41.09	n/a